These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

480 related articles for article (PubMed ID: 9619781)

  • 1. Correlation between oral drug absorption in humans, and apparent drug permeability in TC-7 cells, a human epithelial intestinal cell line: comparison with the parental Caco-2 cell line.
    Grès MC; Julian B; Bourrié M; Meunier V; Roques C; Berger M; Boulenc X; Berger Y; Fabre G
    Pharm Res; 1998 May; 15(5):726-33. PubMed ID: 9619781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Absorption and transport of isoflavonoid compounds from Tongmai formula across human intestinal epithelial (Caco-2) cells in vitro].
    Wang FR; Yang XW
    Zhongguo Zhong Yao Za Zhi; 2017 Aug; 42(16):3206-3212. PubMed ID: 29171242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Permeation of Acamprosate Is Predominantly Caused by Paracellular Diffusion across Caco-2 Cell Monolayers: A Paracellular Modeling Approach.
    Antonescu IE; Rasmussen KF; Neuhoff S; Fretté X; Karlgren M; Bergström CAS; Nielsen CU; Steffansen B
    Mol Pharm; 2019 Nov; 16(11):4636-4650. PubMed ID: 31560549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of HT29-18-C1 and Caco-2 cell lines as models for studying intestinal paracellular drug absorption.
    Collett A; Sims E; Walker D; He YL; Ayrton J; Rowland M; Warhurst G
    Pharm Res; 1996 Feb; 13(2):216-21. PubMed ID: 8932439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Caco-2 versus Caco-2/HT29-MTX co-cultured cell lines: permeabilities via diffusion, inside- and outside-directed carrier-mediated transport.
    Hilgendorf C; Spahn-Langguth H; Regårdh CG; Lipka E; Amidon GL; Langguth P
    J Pharm Sci; 2000 Jan; 89(1):63-75. PubMed ID: 10664539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Absorption of papaverine, laudanosine and cepharanthine across human intestine by using human Caco-2 cells monolayers model].
    Ma L; Yang XW
    Yao Xue Xue Bao; 2008 Feb; 43(2):202-7. PubMed ID: 18507350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of a Human Intestinal Epithelial Cell Monolayer to the Prediction of Oral Drug Absorption in Humans as a Superior Alternative to the Caco-2 Cell Monolayer.
    Takenaka T; Harada N; Kuze J; Chiba M; Iwao T; Matsunaga T
    J Pharm Sci; 2016 Feb; 105(2):915-924. PubMed ID: 26869436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro permeability across Caco-2 cells (colonic) can predict in vivo (small intestinal) absorption in man--fact or myth.
    Yee S
    Pharm Res; 1997 Jun; 14(6):763-6. PubMed ID: 9210194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional Comparison of Human Colonic Carcinoma Cell Lines and Primary Small Intestinal Epithelial Cells for Investigations of Intestinal Drug Permeability and First-Pass Metabolism.
    Yamaura Y; Chapron BD; Wang Z; Himmelfarb J; Thummel KE
    Drug Metab Dispos; 2016 Mar; 44(3):329-35. PubMed ID: 26700954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Caco-2/TC7 cell line characterization for intestinal absorption: how reliable is this in vitro model for the prediction of the oral dose fraction absorbed in human?
    Turco L; Catone T; Caloni F; Di Consiglio E; Testai E; Stammati A
    Toxicol In Vitro; 2011 Feb; 25(1):13-20. PubMed ID: 20732406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of a Caco-2 cell culture model for the characterization of intestinal absorption of antibiotics.
    Biganzoli E; Cavenaghi LA; Rossi R; Brunati MC; Nolli ML
    Farmaco; 1999 Sep; 54(9):594-9. PubMed ID: 10555261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development, validation, and application of a novel 7-day Caco-2 cell culture system.
    Cai Y; Xu C; Chen P; Hu J; Hu R; Huang M; Bi H
    J Pharmacol Toxicol Methods; 2014; 70(2):175-81. PubMed ID: 25034865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new approach to predict human intestinal absorption using porcine intestinal tissue and biorelevant matrices.
    Westerhout J; van de Steeg E; Grossouw D; Zeijdner EE; Krul CA; Verwei M; Wortelboer HM
    Eur J Pharm Sci; 2014 Oct; 63():167-77. PubMed ID: 25046168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human enteroid monolayers as a potential alternative for Ussing chamber and Caco-2 monolayers to study passive permeability and drug efflux.
    Streekstra EJ; Keuper-Navis M; van den Heuvel JJMW; van den Broek P; Stommel MWJ; Bervoets S; O'Gorman L; Greupink R; Russel FGM; van de Steeg E; de Wildt SN
    Eur J Pharm Sci; 2024 Oct; 201():106877. PubMed ID: 39154715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the Caco-2 monolayer as a model epithelium for iontophoretic transport.
    Leonard M; Creed E; Brayden D; Baird AW
    Pharm Res; 2000 Oct; 17(10):1181-8. PubMed ID: 11145222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transport of decursin and decursinol angelate across Caco-2 and MDR-MDCK cell monolayers: in vitro models for intestinal and blood-brain barrier permeability.
    Madgula VL; Avula B; Reddy V L N; Khan IA; Khan SI
    Planta Med; 2007 Apr; 73(4):330-5. PubMed ID: 17372866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Permeability characteristics of parental and clonal human intestinal Caco-2 cell lines differentiated in serum-supplemented and serum-free media.
    Ranaldi G; Consalvo R; Sambuy Y; Scarino ML
    Toxicol In Vitro; 2003; 17(5-6):761-7. PubMed ID: 14599474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An exploratory study of two Caco-2 cell models for oral absorption: a report on their within-laboratory and between-laboratory variability, and their predictive capacity.
    Prieto P; Hoffmann S; Tirelli V; Tancredi F; González I; Bermejo M; De Angelis I
    Altern Lab Anim; 2010 Oct; 38(5):367-86. PubMed ID: 21105755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Caco-2 cells and Biopharmaceutics Classification System (BCS) for prediction of transepithelial transport of xenobiotics (model drug: caffeine).
    Smetanova L; Stetinova V; Kholova D; Kvetina J; Smetana J; Svoboda Z
    Neuro Endocrinol Lett; 2009; 30 Suppl 1():101-5. PubMed ID: 20027153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transport of quercetin and its glucosides across human intestinal epithelial Caco-2 cells.
    Walgren RA; Walle UK; Walle T
    Biochem Pharmacol; 1998 May; 55(10):1721-7. PubMed ID: 9634009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.